Hyaluronic acid vs mitomycin-C for tear duct surgery
Treatments studied
Part of Eyes & vision clinical trials.
This study compares two treatments used during a surgery to unblock the tear duct. The goal is to see which one helps keep the duct open longer and reduces the chance of the blockage returning.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a blocked tear duct (chronic dacryocystitis) that has not been caused by an injury, infection, or other disease.
- You have not had this surgery before on the same eye.
- You do not have any condition that affects wound healing, like uncontrolled diabetes or an autoimmune disease.
- You are not pregnant or breastfeeding.
- You have not used steroid medications (by mouth or on the skin) in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 trial studies whether numbing eye drops (proparacaine 0.5%) can reduce pain during a procedure called probing and irrigation of the tear drainage system. If you need this test for ongoing watery eyes, the trial may help make the procedure more comfortable.
This study tests if adding a medicine called 5-FU to standard tear duct surgery helps people with a small tear drainage sac get better results. It might be an option if you have a blocked tear duct and a very small sac.
This trial tests whether using four balloon inflation points during tear duct surgery works better than the standard two points for people with blocked tear ducts. It aims to improve tear drainage and reduce symptoms.
This study tests a surgery called dacryocystorhinostomy (DCR) that creates a new tear drainage path to stop watery eyes. The surgery is done without a stent (a small tube), and the goal is to relieve symptoms of blocked tear ducts.
This trial tests a new type of dissolvable stent that slowly releases medicine to treat chronic tear duct infections that have come back after previous surgery. It may help people who need another treatment option.
This trial tests whether adding dexmedetomidine or magnesium sulfate to lidocaine makes numbing the eye more effective for tear-duct surgery. The goal is to find which combination provides better pain control during surgery.
Hear when a new Dacryocystitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.